Abstract:Objective To identify the independent risk factors of esophageal varices ( EV) in cirrhosis by endoscopic ultrasonography ( EUS) , and further to establish a risk assessment model for predicting EV occurrence and evaluate the clinical predictive value of the model. Methods A retrospective cohort study was used in this study. Data of patients with cirrhosis without varicosity, who were hospitalized in Tianjin Second People's Hospital from September 2014 to March 2017 were collected. The location, diameter, and number of esophageal collateral circulation were measured by EUS. The non-selective beta blocker ( NSBB) medication history and antiviral therapy were recorded. The time of the first EUS examination was taken as the starting point and the follow-up period was set up as 18 months. The end point was the occurrence of EV or the end of follow-up. The independent risk factors of EV occurrence were determined by univariate and multivariate logistic regression analysis, and the risk assessment model of EV occurrence was constructed. The predictive value of evaluation model for disease was studied by ROC analysis. Hosmer-Lemeshow goodness of fit was used to test the fitting efficiency of the evaluation model. Results A total of 638 subjects were recruited initially, 13 of them were lost in the course of the study. Finally, 625 cases were included in the study. Among them, 369 cases did not develop EV ( the non-progress group) and 256 cases developed EV (the progress group). (1) Multivariate logistic regression analysis showed that 7 independent risk factors were selected into the risk assessment model of EV occurrence, and were assigned corresponding scores:no NSBB (3 points), no antiviral treatment (2 points), Child-Pugh stage B (1 point), the diameter of peri-ECV>2 mm ( 1 point) , the number of peri-ECV≥5 ( 3 points) , the diameter of para-ECV≥5 mm ( 4 points) , and the number of para-ECV≥5 ( 4 points) . ( 2) In the risk assessment model, the risk factor scores ranged from 1 to 4 with a total score of 0-18. The predicted incidence of EV increased from 0. 003 to 1. 000 with the increase of the score. ( 3) In the risk assessment model, the total risk score≤2 was assigned into low-risk group, 3-5 into medium-risk group, and ≥6 into high-risk group. The actual EV incidence of each risk stratification was 2. 78％ in the low-risk group, 36. 36％ in the medium-risk group and 93. 91％ in the high-risk group, respectively. (4) The ROC analysis showed that area under curve (AUC) was 0. 947 (P<0. 05), suggesting that the risk assessment model had a good effect on predicting disease progression. Hosmer-Lemeshow test showed that P was 0. 450, suggesting that the model fitted well. Conclusion The risk assessment model based on EUS can accurately predict the occurrence of EV, and is simple and easy to use. The model can provide scientific basis for the prevention and rational treatment of EV in liver cirrhosis.

Multimodal Ultrasound Model Based on the Left Gastric Vein in B-Viral Cirrhosis: Noninvasive Prediction of Esophageal Varices

Non-invasive Prediction Model for High-Risk Esophageal Varices in the Chinese Population.

Non-invasive model for predicting high-risk esophageal varices based on liver and spleen stiffness

Non-invasive Model for Predicting Esophageal Varices Based on Liver and Spleen Volume

A risk assessment model for esophageal varices occurrence based on endoscopic ultrasonography

Non-Invasive Prediction Models for Esophageal Varices and Red Signs in Patients With Hepatitis B Virus-Related Liver Cirrhosis

Analysis of noninvasive predictive indices of esophageal varices in patients with posthepatitic cirrhosis

Left gastric vein-based noninvasive test for esophageal varices: a same-day comparison of portal hemodynamic assessment with endoscopic appearance

Nomogram for predicting the risk of gastroesophageal varices after primary endoscopic prophylaxis for variceal hemorrhage in patients with cirrhosis

Study of Virtual Touch Tissue Quantification in Noninvasive Assessment of Esophageal Varices in Patients with Hepatitis B Cirrhosis

Prediction Modelling for Gastroesophageal Variceal Bleeding in Patients With Chronic Hepatitis B Using Four-dimensional Flow MRI

A Retrospective Study of Endoscopic Ultrasonography for Predicting Progression of Esophageal Varices in Patients with Hepatitis B Virus-Related Hepatocirrhosis

CT-derived Quantitative Liver Volumetric Parameters for Prediction of Severe Esophageal Varices and the Risk of First Variceal Hemorrhage.

Liver fibrosis index-based nomograms for identifying esophageal varices in patients with chronic hepatitis B related cirrhosis

The ratio of platelet count/spleen diameter and albumin as non-invasive parameters to predict the presence of esophageal varices in patients with liver cirrhosis

Quantitative Liver Volumetric Parameters on Computed Tomography May Be Used for Identifying Severe Esophageal Varices and the Risk of First Variceal Hemorrhage

The therapeutic value of non-invasive indicators in B ultrasonography on predicting esophageal varices and esophageal variceal bleeding

Value of Endoscopic Ultrasonography for Risk Assessment in Esophageal Varices Bleeding

Assessment of nomogram model for the prediction of esophageal variceal hemorrhage in hepatitis B-induced hepatic cirrhosis

Development and validation of a machine learning-based model for varices screening in compensated cirrhosis (CHESS2001): An international multicenter study

New Model Predicting Gastroesophageal Varices and Variceal Hemorrhage in Patients with Chronic Liver Disease